Center for Biomedical Engineering, Brown University, Providence, RI, USA.
Ann Biomed Eng. 2012 Oct;40(10):2079-97. doi: 10.1007/s10439-012-0639-8. Epub 2012 Aug 21.
The goal of tissue engineering is to create a functional replacement for tissues damaged by injury or disease. In many cases, impaired tissues cannot provide viable cells, leading to the investigation of stem cells as a possible alternative. Cartilage, in particular, may benefit from the use of stem cells since the tissue has low cellularity and cannot effectively repair itself. To address this need, researchers are investigating the chondrogenic capabilities of several multipotent stem cell sources, including adult and extra-embryonic mesenchymal stem cells (MSCs), embryonic stem cells (ESCs), and induced pluripotent stem cells (iPSCs). Comparative studies indicate that each cell type has advantages and disadvantages, and while direct comparisons are difficult to make, published data suggest some sources may be more promising for cartilage regeneration than others. In this review, we identify current approaches for isolating and chondrogenically differentiating MSCs from bone marrow, fat, synovium, muscle, and peripheral blood, as well as cells from extra-embryonic tissues, ESCs, and iPSCs. Additionally, we assess chondrogenic induction with growth factors, identifying standard cocktails used for each stem cell type. Cell-only (pellet) and scaffold-based studies are also included, as is a discussion of in vivo results.
组织工程的目标是为因损伤或疾病而受损的组织创建具有功能性的替代品。在许多情况下,受损组织无法提供有活力的细胞,这导致研究人员将干细胞作为一种可能的替代物。特别是软骨可能受益于干细胞的使用,因为该组织细胞数量少,自身无法有效修复。为了满足这一需求,研究人员正在研究几种多能干细胞来源的软骨生成能力,包括成体和胚胎外间充质干细胞(MSCs)、胚胎干细胞(ESCs)和诱导多能干细胞(iPSCs)。比较研究表明,每种细胞类型都有其优点和缺点,虽然直接比较比较困难,但已发表的数据表明,对于软骨再生而言,某些来源可能比其他来源更有前途。在这篇综述中,我们确定了目前从骨髓、脂肪、滑膜、肌肉和外周血中分离和软骨分化 MSCs 的方法,以及来自胚胎外组织、ESCs 和 iPSCs 的细胞的方法。此外,我们还评估了生长因子诱导的软骨生成,确定了每种干细胞类型使用的标准细胞因子混合物。我们还包括仅细胞(微球)和基于支架的研究,并讨论了体内结果。